The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer

BACKGROUND & AIMS: Breast cancer (BC) is prevalent worldwide malignant cancer. Improvements in timely and effective diagnosis and prediction are needed. As reported, secreted DAND5 is contributed to BC metastasis. We aim to assess whether DAND5 in peripheral blood serum could determine BC-specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Yayun, Yao, Ling, Hu, Xin, Huang, Sheng, Huang, Naisi, Li, Shan, Shao, Zhiming, Wu, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924764/
https://www.ncbi.nlm.nih.gov/pubmed/26908452
http://dx.doi.org/10.18632/oncotarget.7498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924764/
https://www.ncbi.nlm.nih.gov/pubmed/26908452
http://dx.doi.org/10.18632/oncotarget.7498

Ejemplares similares